CBSA’s Rocky Mountain Life Science Investor and Partnering Conference will include 40 investors, strategic partners

Thursday September 28, 2017 0 comments Tags: CBSA, Rocky Mountain Life Science Investor Conference, April Giles, Stephanie Gripne, Steve Lindseth

DENVER -- Colorado BioScience Association (CBSA) today announced the full list of investors and strategic partners set to hear company pitches at the 2017 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) from 29 life science companies representing innovation from four Rocky Mountain states.cbsa-investor-conference-2017-logo

The 2017 conference, to be held in Beaver Creek Oct. 2-3, will bring high-profile angel investors, venture capitalists, and representatives from large life science corporations to meet leaders from emerging and established life science companies from Arizona, Colorado, Montana, New Mexico and Utah.

A total of 40 investor representatives will attend, CBSA said.

“The Rocky Mountain Life Science Investor and Partnering Conference brings well-known investors from across the country to meet with our region’s most innovative companies,” said April Giles, CBSA president and CEO.

.”We design this dynamic conference to highlight the breakthroughs coming out of our region. It gives investors and companies the opportunity to get to know each other through formal presentations and informal networking sessions in a relaxed mountain environment.”

Participating investment firms include:

 

 

 

 

Angel Investors

Lightstone Ventures

Aphelion Capital

McGregor & Associates

Artiman

Medtronic

AngelMD

Meridian Street Capital

Boomtown Accelerator

Merck

Boulder Ventures

NanoDimension

Charter Life Sciences

Ne Enterprise Associates

Colorado Impact Fund

Oxford Finance

GSK

Providence Ventures

Green Park and Golf Ventures

Samsung Ventures

HealthQuest Capital

Sanderling Ventures

High Country Ventures

Triple Tree

Hyalescent Ventures

UCHealth CARE Innovation Center

Kensington Ventures

Volcano Capital

KMG Capital Partners

 

White Hat Health Ventures

 

Following a breakfast keynote presentation on bioscience and impact investing by Stephanie Gripne, founder and executive director of the Impact Finance Center, investors and partners will hear pitches from the 29 companies chosen to present.

For the first time, the presenting companies include three publicly traded firms, ARCA Biopharma, miRagen and ProLung.

Steve Lindseth, senior advisor at Triple Tree Capital Partners, will discuss the investment landscape for healthcare innovation from the investor perspective during the lunch keynote.

The 2017 Rocky Mountain Life Science Investor and Partnering Conference, led by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah, will kick off with a cocktail networking reception at Beaver Creek’s Park Hyatt Hotel on Oct. 2, followed by a full day of company pitch presentations on Oct. 3.

A full agenda can be found online.